Yarrow Bioscience Overview

  • Status
  • Public

  • Investments
  • 1

Yarrow Bioscience General Information

Description

Operator of a biopharmaceutical company intended to create novel therapies for chronic and inflammatory diseases. The company offers a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves' disease and thyroid eye disease, enabling clinicians to utilize transformative therapeutics for the treatment of autoimmune thyroid diseases.

Contact Information

Website
www.yarrowbioscience.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 470 James Street
  • Suite 007
  • New Haven, CT 06513
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 470 James Street
  • Suite 007
  • New Haven, CT 06513
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Yarrow Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Yarrow Bioscience‘s full profile, request access.

Request a free trial

Yarrow Bioscience Patents

  • 179

    Total Documents Applications and Grants

  • Total Patents Families

  • 77

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Yarrow Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026128622-A1 Bet inhibitors for use in treating an inflammatory, an immune-mediated, or an autoimmune disease Pending 11-Dec-2024
US-20260285861-A1 Selective bet inhibitors and uses thereof Pending 17-Aug-2023
WO-2024220589-A3 Uses of pan bet inhibitors Inactive 18-Apr-2023
WO-2024220589-A8 Uses of pan bet inhibitors Inactive 18-Apr-2023
WO-2024220589-A2 Uses of pan bet inhibitors cross-reference to related applications Inactive 18-Apr-2023 C07D471/04
To view Yarrow Bioscience’s complete patent history, request access »

Yarrow Bioscience Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Yarrow Bioscience‘s full profile, request access.

Request a free trial

Yarrow Bioscience Acquisitions (1)

Yarrow Bioscience’s most recent deal was a Merger/Acquisition with VYNE Therapeutics. The deal was made on 27-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
VYNE Therapeutics 27-Jun-2026 Merger/Acquisition Drug Discovery
To view Yarrow Bioscience’s complete acquisitions history, request access »

Yarrow Bioscience FAQs

  • Where is Yarrow Bioscience headquartered?

    Yarrow Bioscience is headquartered in New Haven, CT.

  • What industry is Yarrow Bioscience in?

    Yarrow Bioscience’s primary industry is Drug Discovery.

  • Is Yarrow Bioscience a private or public company?

    Yarrow Bioscience is a Public company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process